Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SCCP and fluoride

This article was originally published in The Tan Sheet

Executive Summary

Oral hygiene products with maximum fluoride concentrations of 0.15% (1500 ppm) still are safe for use for children under the age of six, the European Commission's Scientific Committee on Consumer Products concludes during its fifth plenary meeting Sept. 20. The group reviewed data presented by a member state that suggested toothpaste formulations containing 500-700 ppm fluoride would be more appropriate for children under six. SCCP said most of the points raised by the member state already had been addressed previously and reiterated that toothpaste with 0.15% (1500 ppm) fluoride "is effective at preventing dental caries in all age groups." Additionally, "below 1000 ppm, the cariostatic effect of fluoride is not established"...

You may also be interested in...



Sales Already Growing As Vascepa Secures Cardio Approval

Company forecasts 2020 sales as high as $700m after regulator grants broad label.

Another EU MDR Notified Body In The Netherlands

Last week, the European Commission revealed that three more notified bodies had been designated, but their listings had not been made official. Now we learn that one of the three is in the Netherlands as the first listing takes place.

Belgium Outlaws OTC Cough And Cold Combination Drugs

Safety concerns prompt Belgium's drug regulator to order all OTC fixed combination products for coughs and colds removed from shelves.

Topics

UsernamePublicRestriction

Register

PS098764

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel